Scans - PET-CT, etc.

Scans - PET-CT, etc.

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses optimal follow up for patients after resection of an early-stage non-small cell lung cancer (NSCLC).
Cancer Journey:
Cancer Type:
Disease Learning:
,
,
Download the speaker presentations and handouts from the Targeted Therapies Patient Forum in Cleveland at the Taussig Cancer Center on September 16, 2017.
Cancer Type:
For our 12th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss what a PET scan is.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jed Gorden, Swedish Cancer Institute, reviews the lung cancer screening process, including low-dose CT scanning, smoking cessation, follow-up testing and counseling, and describes the potential benefits.
Cancer Journey:
Cancer Type:
Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging.
Cancer Journey:
Cancer Type:

Articles

Dr. Nasser Hanna, Indiana University Health, addresses the issue of prophylactic cranial irradiation (PCI) in locally advanced NSCLC.
Cancer Journey:
Cancer Type:
Dr. Mark Socinski, University of Pittsburgh Medical Center, describes strategies for treatment of the elderly and frail patient with locally advanced NSCLC.
Cancer Journey:
Cancer Type:
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides trial evidence showing that patients may not benefit from high dose chest radiation therapy vs. standard dose therapy.
Cancer Journey:
Cancer Type:
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy options for treatment of both sensitive and refractory small cell lung cancer (SCLC).
Cancer Journey:
Cancer Type:
UCLA Med Center's Dr. Eddie Garon discusses the open question of the optimal duration of ongoing treatment with immunotherapy for lung cancer.
Cancer Journey:
Cancer Type:

Community Forum

No Result Found